CEO Richard Christopher shared insights on their DehydraTECH technology, a game-changing drug delivery enabling technology focused on the GLP-1 marketplace
A GP, pharmacist, or specialist clinician can: Review your current medication list for potential interactions, particularly with diabetes medications, anticoagulants, thyroid treatments, and hormonal contraceptives Assess your nutritional status and advise on appropriate supplementation only where deficiencies are confirmed Monitor for adverse effects such as hypoglycaemia, gastrointestinal disturbance, or unexpected changes in blood pressure or heart rate Refer you to appropriate NHS services , including Tier 3 weight management programmes, if you are seeking structured support for obesity Discuss contraception and family planning , as retatrutide should not be used during pregnancy or breastfeeding
The active ingredient, liraglutide, is a glucagon-like peptide-1 (GLP-1) receptor agonist
It is a starting point, not a complete picture
Treating endometriosis inflammation with GLP-1s